Reduction of KLRG1+CD8+ T cells in tumor-bearing mice significantly attenuated the tumor clearance effects of Vax/aGITR/aPD-1 therapy and allowed the tumors to grow larger compared to the non-treated KLRG1 mAb therapeutic group (Figure 6D). This evidence concerns the gene CD8A and neoplasm.